Professor Sunil Lakhani is a clinical diagnostic and molecular pathologist. He is a Senior Staff Specialist, at Pathology Queensland and a Group Leader, at Molecular Breast Pathology, University of Queensland Centre for Clinical Research, Brisbane, Australia.

Research interests include lobular carcinoma, triple negative and metaplastic breast cancer, and therapeutic development of brain metastases.

He was the Editor of the WHO 4th and 5th Ed Tumours of the Breast (2012, 2019). He is the recipient of the Distinguished Pathologist Medal, Australasian Division of IAP, and the Distinguished Fellow Award from the Royal College of Pathologists of Australasia. In 2017, he was elected a Fellow of the Australian Academy of Health and Medical Sciences.

He is the current Chair, of the Board of Directors, Breast Cancer Trials (BCT).